Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02
Among patients treated with the anticonvulsive and psychotropic drug carbamazepine (CBZ), approximately 10% develop severe and life-threatening adverse drug reactions. These immunological conditions are resolved upon withdrawal of the medicament, suggesting that the drug does not manifest in the bod...
Saved in:
Main Authors: | Gwendolin S. Simper, Gia-Gia T. Hò, Alexander A. Celik, Trevor Huyton, Joachim Kuhn, Heike Kunze-Schumacher, Rainer Blasczyk, Christina Bade-Döding |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2018/5086503 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients
by: Chonlaphat Sukasem, et al.
Published: (2018-01-01) -
Neuroleptic Malignant Syndrome Caused by a Combination of Carbamazepine and Amitriptyline
by: A. Bruce Janati, et al.
Published: (2012-01-01) -
Pharmacovigilance of carbamazepine at the Marta Abreu Polyclinic. Santa Clara, 2022
by: Adrián Ruíz López
Published: (2023-02-01) -
Stevens-Johnson Syndrome following Failure of Genetic Screening prior to Carbamazepine Prescription
by: Suraya Ahmad Nasir, et al.
Published: (2017-01-01) -
Carbamazepine Induced Stevens-Johnson Syndrome That Developed into Toxic Epidermal Necrolysis: Review of the Literature
by: Yousef S. Abuzneid, et al.
Published: (2022-01-01)